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At 17+4 week, non-invasive prenatal testing (NIPT) results of a 24-years-old mother showed high risk of monosomy
X (45, X). Abnormally shaped head and cardiac defects were observed in prenatal ultrasound scan at 19+3 week.
Amniocentesis conducted at 19+3 week identified karyotype 47, XX, +18, which suggested that the NIPT failed to
detect trisomy 18 (T18) in this case. With a further massively parallel sequencing (MPS) of maternal blood, fetal
and placental tissues, we found a confined placental mosaicism (CPM) with non-mosaic T18 fetus and multiclonal
placenta with high prevalence of 45, X and low level of T18 cells. FISH and SNP-array evidence from the placental
tissue confirmed genetic discrepancy between the fetus and placenta. Because the primary source of the fetal
cell-free DNA that NIPT assesses is mostly originated from trophoblast cells, the level of T18 placental mosaicism
may cause false negative NIPT result in this rare case of double aneuploidy.
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Non-invasive prenatal testing for common fetal aneu-
ploidies, in particular trisomy 21 and 18, by massively
parallel sequencing (MPS) of maternal plasma DNA is
an extremely efficient screening test with sensitivity and
specificity of over 99% [1].Case presentation
Here we report a rare case with mosaic monosomy X and
trisomy 18 in placenta, which induced a false negative NIPT
result. Results of the 2nd trimester combined test (AFP
0.65 MoM and hCGb 4.32 MoM) indicated that the preg-
nancy of the 24-year-old mother (“gravida 2, para 0”, G2P0)
was at high risk of Down syndrome (1/45). As the following
screening, a NIPT test was then performed at 17+4 week
of gestation by maternal peripheral blood collection,* Correspondence: njfybjyhuping@163.com; rosening@163.com
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unless otherwise stated.cell-free DNA (cfDNA) extraction, library construction
and sequencing through Illumina HiSeq2000 platform [2].
However, the NIPT did not reveal risks of fetal trisomy
13, 18 or 21, but demonstrated a great probability of 45,
X. This was a female fetus. The t-score for chromosome
18 was −0.52, but for chromosome X was about −4.05,
which suggests that the NIPT result was 45, X. Ultra-
sound scan at 19+3 week showed strawberry-shaped head
and ventricular septal defect (VSD) (Figure 1). After
consulting, the patient agreed to take a further amnio-
centesis for confirmation of NIPT results. G-banding of
amniocytes cultivation identified the fetal karyotyping
result as 47, XX, +18 (Figure 2) and implied that the
NIPT had given a false negative result of T18. After
post-test consultation, the couple decided to terminate
pregnancy and agreed on additional research. Sequen-
cing results of NIPT (Figure 3) identified the aborted
fetal tissue as T18 condition, while the placental tissue
as a status of mosaic T18 (mosaic ratio nearly 30%) and
45, X (mosaic ratio nearly 60%), which was in agreement
with the amniocentesis result. Moreover, FISH analyses
using chromosome 18 and X specific probes on placen-
tal tissues identified a combination of 45, X and T18. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Abnormal sonographic features of fetus at 19th week. A. strawberry-shaped head. B. Four-chamber view of the fetal heart showing
a ventricular septal defect (0.6 cm diameter).
Pan et al. Molecular Cytogenetics 2014, 7:48 Page 2 of 5
http://www.molecularcytogenetics.org/content/7/1/48mosaicism, with high level of 45, X cells (67%, 62/92)
and relatively low abundance of T18 cells (30%, 28/92)
in total (Figure 4). This is also confirmed by SNP-array
results of placental samples which offered clear evidence
for the various level of 45, X and T18 mosaicism. The
SNP-array results (Figure 5) with the signal intensity
(logR) and genotyping (B allele frequency, BAF) value
plots indicated the mosaic rearrangements. The increased
logR and altered BAF value (Figure 5B) suggested a mo-
saic trisomy of chromosome 18 in 50% of the cells. The
level of mosaicism was determined based on both logR
and BAF value [3]. Notably, the result indicated partial
duplication for the distal section of 18q represented in
17% of the cells, which was evidenced by the observa-
tion of two additional chromatin segments attached to aFigure 2 Conventional karyotype analysis of cultured amniocytes shochromosome 18 in the FISH results (Figure 4). On the
other hand, large mosaic deletion ranging in size from
31.05 to 93.16 Mb of chromosome X was illustrated in
Figure 5C. The decreased logR and abnormal heterozy-
gous BAF value indicated a mosaic monosomy at the
level of 67%, which showed good agreement with the
FISH results.
To the contrary, G-banding, FISH and SNP-array ana-
lyses on the post-mortem fetal tissue all demonstrated
positive results of complete T18, showing that the fetal
tissue is genetically different from the placental tissue.
Analysis and conclusion
It is acknowledged that fetal cfDNA in maternal periph-
eral blood is originated from trophoblast and mainlyws the fetal karyotype as 47, XX, +18 (trisomy 18).
Figure 3 The MPS results of maternal peripheral blood DNA, fetal DNA, placental DNA. A-B. The maternal information of chromosome
18 and X, based on the sequencing result of maternal peripheral blood DNA, suggests a euploid status of the maternal background. C-D. The
sequencing results of fetal DNA, where the copy ratio (1.5) of chromosome 18 in C indicated the trisomy 18 status in the fetus, the copy ratio
(1.0) of chromosome X in D indicated the euploid status of chromosome X in the fetus. E-F. The sequencing results of the placental DNA, where
the copy ratio (1.0-1.5) of chromosome 18 in E indicated a low level of mosacism of trisomy 18, the copy ratio (0.5-1.0) in F indicated a low level
of mosaicism of monosomy X.
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Figure 4 FISH analysis results of placental tissue showed the combination status of 45, X and trisomy 18 mosaicism, with DNA of
chromosome 18 marked as aqua (A) and chromosome X as green (G). The cells with karyotype 47, XX, +18 were indicated as 2G3A, while
the 45, X cells were indicated as 1G2A. Two additional chromatin segments attached to a chromosome 18 were observed in a cell (2G3A) on the
left, suggesting partial duplications in addition to trisomy 18.
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cordance between placental and fetal tissue may affect the
NIPT test and lead to inaccurate results. False positive
NIPT results, small but not negligible, have been reported
and noted for concern in these years [6-8]. In addition,Figure 5 Illumina SNP array result showing the presence of mosaicism
of SNP array (Illumina HumanCytoSNP-12). The upper axis indicates the valu
(1 for BB, 0.5 for AB and 0 for AA) in a diploid individual. Additionally, the l
of each SNP compared to diploid individuals in chromosome 18 (a logR ra
with mosaic trisomy 18. The BAF values (1 for BBB and BB; 0.6 for ABB and
ratio indicated a mosaicism. Partial duplication in distal region of 18q was a
array (Illumina HumanCytoSNP-12). D. A SNP array of placental tissue with
for AA and AO; 0 for AA) and the decreased logR ratio indicated a mosaicismosaic condition of placenta may reduce the measure-
ment accuracy and cause false negative result. The present
case offered strong evidence for the idea and was sup-
ported by a previous case of double trisomy in placenta
[9]. In this case, the fraction of fetal cfDNA for T18of placental tissue. A. A view of normal chromosome 18 as control
e of B allele frequency (BAF, blue dots). BAF may have three values
ower axis indicates the logR ratio (red line), where R illustrates the ratio
tio of 0 means an actual ratio of 1). B. A SNP array of placental tissue
AB; 0.4 for AAB and AB; and 0 for AAA and AA) and the increased logR
lso observed. C. A view of normal chromosome X as control of SNP
mosaic monosomy X. The BAF values (1 for BB; 0.75 for BB and BO; 0.25
m.
Pan et al. Molecular Cytogenetics 2014, 7:48 Page 5 of 5
http://www.molecularcytogenetics.org/content/7/1/48caused by mosaic placenta is considerably lower than the
detection threshold of NIPT test and consequently caused
false negative results. Therefore, the level of mosaicism is
an important factor for the NIPT test.
Collectively, considering the effect from placenta, the
NIPT results should be interpreted combining other clin-
ical tests under comprehensive background information.
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